首页> 外文OA文献 >24 Weeks Treatment with Pegylated Interferon Alfa Plus Ribavirin May Be Possible in Genotype 1 Chronic Hepatitis C Patients with Rapid Virological Response Who Have Low Pretreatment Viremia

【2h】

24 Weeks Treatment with Pegylated Interferon Alfa Plus Ribavirin May Be Possible in Genotype 1 Chronic Hepatitis C Patients with Rapid Virological Response Who Have Low Pretreatment Viremia

机译：24周用Pegymated干扰素Alfa plus利巴韦林治疗，在基因型1慢性丙型肝炎患者中可能有可能具有低预处理病毒血症的快速病毒学反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sung Soo Moon; Hyoun Gu Kang; Jeong Ah Seo; Eun Uk Jung; Sang Heon Lee; Sung Jae Park; Youn Jae Lee; Sang Yong Seol;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. [J] . Zeuzem S, Buti M, Ferenci P, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2006,第1期

机译：聚乙二醇干扰素α-2b加利巴韦林治疗基因型1和低预处理病毒血症的慢性丙型肝炎患者24周的疗效。
2. A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rate [J] . Rivero-JuarezA., López-CortésL.F., CamachoA., Clinical infectious diseases . 2014,第1期

机译：HIV /丙型肝炎病毒基因型3合并感染患者的聚乙二醇干扰素/利巴韦林24周治疗策略获得了快速的病毒学应答，导致持续的病毒学应答率高
3. Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response [J] . Dalgard O, Bjoro K, Ring-Larsen H, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2008,第1期

机译：丙型干扰素α和利巴韦林治疗丙型肝炎病毒基因型2或3和快速病毒学应答的患者相对于14周和24周
4. Patients with HCV/HIV Co-infection Achieving a Sustained Virological Response Following HCV Treatment with Peginterferon alfa-2a (PEGASYS) plus Ribavirin (COPEGUS) have Improved Health Related Quality of Life [C] . D.T. Dieterich, M. Rodriguez Torres, J.K. Rockstroh International AIDS Conference . 2004

机译：HCV / HIV的患者在用Peginterferon Alfa-2a（Pegasys）加上利巴韦林（Copegegs）后HCV治疗后实现持续的病毒学反应，具有改善的健康相关的生活质量
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Rapid Virological Response to Peginterferon Alfa and Ribavirin Treatment of Chronic Hepatitis C Predicts Sustained Virological Response and Relapse in Genotype 1 Patients [O] . Fred Poordad, Carmen Landaverde 2009

机译：对Peginterferon Alfa和利巴韦林的快速病毒学应答慢性丙型肝炎的治疗可预测持续的病毒学应答和基因1型患者复发
7. Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response [O] . Dalgard, Olav, Bjoro, Kristian, Ring-Larsen, Helmer, 2008

机译：聚乙二醇化干扰素α和利巴韦林在丙型肝炎病毒基因型2或3患者中的14周和24周以及快速病毒学应答

24 Weeks Treatment with Pegylated Interferon Alfa Plus Ribavirin May Be Possible in Genotype 1 Chronic Hepatitis C Patients with Rapid Virological Response Who Have Low Pretreatment Viremia

著录项

引文网络

相似文献

相关主题

期刊订阅